Cargando…

Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19

OBJECTIVE: Dexamethasone, remdesivir (REM), and baricitinib (BAR) are commonly used to treat coronavirus disease 2019 (COVID-19). High-dose steroids have also been reported to be well tolerated, even when used in combination with multiple drugs. In this retrospective study, we assessed the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagasawa, Ryo, Niwa, Takashi, Hagiwara, Eri, Oda, Tsuneyuki, Yamada, Sho, Okuda, Ryo, Baba, Tomohisa, Komatsu, Shigeru, Kaneko, Takeshi, Ogura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686726/ https://www.ncbi.nlm.nih.gov/pubmed/37438142 http://dx.doi.org/10.2169/internalmedicine.0761-22

Ejemplares similares

Clinical characteristics of Japanese patients with moderate to severe COVID-19
por: Otoshi, Ryota, et al.
Publicado: (2021)

Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy
por: Okabayashi, Hiroko, et al.
Publicado: (2020)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia
por: Kitayama, Takaaki, et al.
Publicado: (2020)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
por: Yamaya, Takafumi, et al.
Publicado: (2021)

Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
por: Okuda, Ryo, et al.
Publicado: (2022)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
por: Otoshi, Ryota, et al.
Publicado: (2019)

Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease
por: Sato, Yozo, et al.
Publicado: (2022)

Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia
por: Oda, Tsuneyuki, et al.
Publicado: (2022)

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
por: Okabayashi, Hiroko, et al.
Publicado: (2021)

Transbronchial lung cryobiopsy in idiopathic acute fibrinous and organizing pneumonia
por: Shintani, Ryota, et al.
Publicado: (2019)

Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity
por: Aoki, Ryo, et al.
Publicado: (2021)

Successful Treatment of Chylothorax and Chylopericardium by Radiotherapy in Lung Cancer
por: Shintani, Ryota, et al.
Publicado: (2021)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
por: Okuda, Ryo, et al.
Publicado: (2023)

Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study
por: So, Jessica M, et al.
Publicado: (2021)

Pilot Quasi-Randomized Controlled Study of Herbal Medicine Hochuekkito as an Adjunct to Conventional Treatment for Progressed Pulmonary Mycobacterium avium Complex Disease
por: Enomoto, Yasunori, et al.
Publicado: (2014)

Small-cell lung carcinoma transformation of lung adenocarcinoma diagnosed by pericardial effusion: A case report
por: Otoshi, Ryota, et al.
Publicado: (2020)

Relationship of flow-volume curve pattern on pulmonary function test with clinical and radiological features in idiopathic pulmonary fibrosis
por: Nakagawa, Hiroaki, et al.
Publicado: (2020)

Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria
por: Asaoka, Masato, et al.
Publicado: (2021)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
por: Yamaya, Takafumi, et al.
Publicado: (2022)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2019)

Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2017)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Pneumothorax in a COVID-19 Pneumonia Patient without Underlying Risk Factors
por: Yamaya, Takafumi, et al.
Publicado: (2020)

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023)

Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease
por: Muto, Yutaka, et al.
Publicado: (2022)

Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven Case
por: Otoshi, Ryota, et al.
Publicado: (2019)

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
por: Sato, Yozo, et al.
Publicado: (2021)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022)

Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1
por: Katano, Takuma, et al.
Publicado: (2020)

The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study
por: Okabayashi, Hiroko, et al.
Publicado: (2022)

A Retrospective Study of the Clinical, Radiological, and Pathological Characteristics of Patients with Interstitial Pneumonia Preceding Rheumatoid Arthritis
por: Sato, Midori, et al.
Publicado: (2022)

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
por: Izumo, Takehiro, et al.
Publicado: (2021)

Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
por: Yasuda, Yuto, et al.
Publicado: (2022)

Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir
por: Oda, Naohiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sva683ntka7su2htkfd79u8214